Man­u­fac­tur­ing roundup: So­ci­etal CD­MO nets new cus­tomers; Chime Bi­o­log­ics gets the OK to man­u­fac­ture an­ti­bod­ies

So­ci­etal CD­MO has been award­ed ser­vice con­tracts for three new cus­tomers. The agree­ments in­clude an ar­ray of man­u­fac­tur­ing ser­vices, for clin­i­cal tri­als, an­a­lyt­i­cal meth­ods, for­mu­la­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.